Expertise in

conditions

Ketty Peris

Rome, IT

Expertise in

conditions

Rome, IT

Overview

Ketty Peris practices practicing medicine in Rome, Italy.

Ms. Peris is highly rated in 31 conditions, according to our data. Her clinical expertise encompasses Basal Cell Skin Cancer, Atopic Dermatitis, Psoriasis, Kidney Transplant, and Liver Transplant.

She is actively involved in clinical research, co-authoring 585 peer reviewed articles and participating in 7 clinical trials.

Gender

Female

Locations

Rome, Italy

Other Locations

Italy

Milan, Italy

Modena, Italy

L'aquila, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)

Enrollment Status: Completed

Publish Date: November 05, 2025

Intervention Type: Biological

Study Drug: Lebrikizumab

Study Phase: Phase 3

A Phase 3 Multicenter, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Adult Patients With Atopic Dermatitis

Enrollment Status: Completed

Publish Date: September 03, 2024

Intervention Type: Drug

Study Drug: Baricitinib

Study Phase: Phase 3

A Multicenter, Randomized, Double-blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome

Enrollment Status: Completed

Publish Date: July 03, 2024

Intervention Type: Drug

Study Phase: Phase 3

A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis.

Enrollment Status: Completed

Publish Date: May 24, 2023

Intervention Type: Biological, Other

Study Drug: Lebrikizumab

Study Phase: Phase 3

A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3

Enrollment Status: Terminated

Publish Date: March 21, 2023

Intervention Type: Drug

Study Drug: Mirikizumab

Study Phase: Phase 3

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2

Enrollment Status: Completed

Publish Date: March 30, 2021

Intervention Type: Drug

Study Phase: Phase 3

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate to Severe Atopic Dermatitis BREEZE-AD7

Enrollment Status: Completed

Publish Date: August 11, 2020

Intervention Type: Drug

Study Phase: Phase 3

View 6 Less Clinical Trials

584 Total Publications

Corrigendum to "Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology" [Digestive and Liver Disease 58 (2026) 1051-1060].

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: August 30, 2026

View All 584 Publications

Frequently Asked Questions about Ketty Peris

Is Ketty Peris a top-rated expert for Basal Cell Skin Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Ketty Peris is classified as an Elite expert for Basal Cell Skin Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ketty Peris participate in research or clinical trials?

Yes. Ketty Peris has published 584 articles and abstracts on conditions like Basal Cell Skin Cancer. You can view a list of Ketty Peris's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Peris's expertise for a condition

ConditionClose